The company will collaborate with Duke on cancer biomarker discoveries, and intends to use and commercialize the markers through agreements with drug developers.
The NC-based startup is led by a former LabCorp executive and is seeking partnerships to bring molecular diagnostic products to market.
Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.
CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.
The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.
In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.